Log In
BCIQ
Print this Print this
 

MAP kinase kinase 2 (MAP2K2) (MEK2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting MAP kinase kinase 2 (MAP2K2) (MEK2)

BCIQ
Print ChartPrint this
1 2 1 3 1 1
Phases of DevelopmentPreclinicalPhase IPhase I/IIPhase IIRegistrationMarketed
Cancer

1

2

1

3

1

1




 Products Targeting MAP kinase kinase 2 (MAP2K2) (MEK2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$16,000.0M

$14,500.0M

$1,500.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today